Zhenzhong Chen Selected Research

LT-171-861

1/2021

Inhibition of Pim-2 kinase by LT-171-861 promotes DNA damage and exhibits enhanced lethal effects with PARP inhibitor in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenzhong Chen Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 04/2020
4	Osteoporosis 01/2022 - 12/2018
2	Bone Resorption 10/2021 - 12/2018
1	Osteosarcoma (Osteogenic Sarcoma) 11/2021
1	Cataract (Cataracts) 05/2021
1	Multiple Myeloma 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 04/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Osteolysis 01/2019
1	Compression Fractures (Compression Fracture) 12/2018
1	Intervertebral Disc Degeneration 10/2017
1	Edema (Dropsy) 09/2014

Drug/Important Bio-Agent (IBA)

2	RepSoxIBA 11/2021 - 12/2018
2	Pharmaceutical PreparationsIBA 10/2021 - 04/2020
2	Estrogens (Estrogen)FDA Link 01/2019 - 10/2017
1	Chimeric Antigen ReceptorsIBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2021
1	pontamine sky blueIBA 10/2021
1	LT-171-861IBA 01/2021
1	olaparibIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Angiogenesis InhibitorsIBA 04/2020
1	AlginatesIBA 04/2020
1	Fibrinogen (Factor I)FDA Link 04/2020
1	Sunitinib (Sutent)FDA Link 04/2020
1	Temozolomide (Temodar)FDA LinkGeneric 04/2020
1	TubulinIBA 01/2020
1	TitaniumIBA 01/2019
1	LigandsIBA 12/2018
1	Xylenes (Xylene)IBA 09/2014
1	omphalocarpinIBA 09/2014

Therapy/Procedure

2	Ovariectomy (Oophorectomy) 01/2019 - 12/2018
1	Therapeutics 01/2022
1	Lenses 05/2021
1	Vertebroplasty 12/2018